Originally, the Danish company Novo Nordisk wanted to develop Semaglutid as a drug for diabetes 2 patients. However, the appetite-reducing effect of the drug soon became apparent, making semaglutide a miracle cure for obesity. While Novo Nordisk’s share price has risen significantly since then, possible side effects of the drug are now also being examined.
![Miracle drug semaglutide: slim by injection Miracle drug semaglutide: slim by injection](https://blog.en.erste-am.com/wp-content/uploads/2023/08/i-yunmai-5jctAMjz21A-unsplash.jpg-370x210-1691750878.png)